Cambiar Investors LLC Novartis Ag Transaction History

Cambiar Investors LLC

$2.4 Billion
Q4 2024

A detailed history of Cambiar Investors LLC transactions in Novartis Ag stock. As of the latest transaction made, Cambiar Investors LLC holds 121,975 shares of NVS stock, worth $12.8 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

121,975

Previous 125,609 2.89%

Holding current value

$12.8 Million

Previous $14.4 Million 17.84%

% of portfolio

0.49%

Previous 0.59%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$96.78 - $117.18 $351,698 - $425,832	-3,634 Reduced 2.89%	121,975 $11.9 Million
Q3 2024 Oct 28, 2024	SELL	$106.13 - $120.89 $9.66 Million - $11 Million	-91,047 Reduced 42.02%	125,609 $14.4 Million
Q2 2024 Jul 26, 2024	BUY	$92.57 - $107.37 $6.94 Million - $8.05 Million	74,938 Added 52.88%	216,656 $23.1 Million
Q1 2024 May 02, 2024	SELL	$95.27 - $108.47 $1.37 Million - $1.56 Million	-14,406 Reduced 9.23%	141,718 $13.7 Million
Q4 2023 Jan 25, 2024	SELL	$92.27 - $101.54 $7.62 Million - $8.38 Million	-82,537 Reduced 34.58%	156,124 $15.8 Million
Q3 2023 Oct 30, 2023	SELL	$94.73 - $105.13 $1.64 Million - $1.82 Million	-17,292 Reduced 6.76%	238,661 $24.3 Million
Q2 2023 Jul 31, 2023	SELL	$92.52 - $104.91 $4.79 Million - $5.43 Million	-51,753 Reduced 16.82%	255,953 $25.8 Million
Q1 2023 May 08, 2023	BUY	$80.03 - $92.81 $280,024 - $324,742	3,499 Added 1.15%	307,706 $28.3 Million
Q4 2022 Feb 02, 2023	SELL	$75.55 - $92.52 $1.97 Million - $2.41 Million	-26,041 Reduced 7.89%	304,207 $27.6 Million
Q3 2022 Oct 28, 2022	BUY	$74.61 - $87.26 $24.6 Million - $28.8 Million	330,248 New	330,248 $25.1 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $225B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.

Account

Cambiar Investors LLC Novartis Ag Transaction History